About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA). For additional information, please see the “About Access to Information Requests” webpage.
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 32 record(s)
Req # A 2023_0011
1. Any document or information concerning the granting of the “Politically-Exposed Persons” (“PEP”) status upon individuals in Canada or elsewhere. 2. The complete list of individuals upon which the PEP status has been granted over the past 15 years. 3. The list of individuals who are currently designated as PEPs. 4. The involvement of your organization or government institution in the granting, maintenance or communication of the PEP status conferred upon individuals 5. A complete list of organizations, government institutions and third parties that have access to or are informed of the PEP status.Organization: Canada Development Investment Corporation
February 2024
Req # A-2024-54596
Submission of the Public Health Agency of Canada (PHAC) to the Patented Medicine Prices Review Board’s November 2023 consultation on the Scoping paper of the Board's Guidelines. Submissions from other stakeholders can be viewed here: https://www.canada.ca/en/patented-medicine-prices-review/services/consultations/scoping-paper-board-guidelines.htmlOrganization: Patented Medicine Prices Review Board Canada
February 2024
Nothing to report this month
Organization: Canada Development Investment Corporation
Nothing to report this month
Organization: Nanaimo Port Authority
Req # A 2022_0007
The total compensation (salary + benefits) paid out to executives for the calendar years 2020, 2021 and 2022. Include a breakdown of the different types of benefits paid out including any performance or incentive pay received for each year. Please provide ranges if exact amounts cannot be provided. Please also provide a total number of executives at the corporation for each year.”Organization: Canada Development Investment Corporation
February 2023
Req # A 2022_0008
Documentation on the number of employees who have received pay increases during 2020, 2021 and 2022 (broken down by year), including step pay increases, but do not include pay raises due to promotions to new positions. Please also provide the amount of employees who received pay cuts during the same time periods, as well as corresponding amounts – but excluding those employees who left their positions.Organization: Canada Development Investment Corporation
February 2023
Req # A 2022_0010
Documentation on the amounts and number of employees who have received bonuses or other forms of performance incentives for 2020, 2021 and 2022. Provide the annual breakdown or equivalent for each calendar year (or fiscal if calendar not possible).Organization: Canada Development Investment Corporation
February 2023
Req # A-2023-02395
Copies of all correspondence and communications between the (then) acting chairperson of the Patented Medicines Prices Review Board Mélanie Bourassa-Forcier and Innovative Medicines Canada (IMC) between October 1, 2022 and December 5, 2022 regarding the PMPRB's new draft guidelines and the consultation process. Please include all responses to Innovative Medicines Canada (IMC)'s communications/correspondence from the (then) acting chairperson of the Patented Medicines Prices Review Board Mélanie Bourassa-Forcier.Organization: Patented Medicine Prices Review Board Canada
February 2023
Req # A-2022-09063
Copies of any emails sent by the Vice-chair regarding any of the following topics: (i) her resignation or intent to resign or the reasons for her resignation. (ii) the draft guidelines. (iii) the consultation process for the draft guidelines. (iv) the impact of the Merck Canada, IMC, and/or Alexion court decisions on the PMPRB, including its draft guidelines. From November 1, 2022 to December 5, 2022.Organization: Patented Medicine Prices Review Board Canada
February 2023
Req # A-2022-09228
All correspondence between PMPRB Board members and PMPRB staff pertaining to the October 2022 revised draft Guidelines and the resignation of the PMPRB Acting Chairperson, Mélanie Bourassa-Forcier. “Correspondence” includes written correspondence, call notes, email, text messaging, instant messaging, and any other form of electronic communication.Organization: Patented Medicine Prices Review Board Canada
February 2023